go back

Brexucabtagene Autoleucel (Tecartus) CAR-T Therapy

Massachusetts rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $537,032 · 10th–90th $426,580$1,288,2500%20%10th90th$537,032Professionalmedian $489,779 · 10th–90th $489,779$630,9570%50%90th$489,779$100.0$1.0K$10.0K$100.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$977,237.22
Aetna
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$660,693.45
AllWays Health Partners
Setting
Facility
Modifier
Global
Typical Low
$426,579.52
Median
$977,237.22
Typical High
$1,659,586.91
AllWays Health Partners
Setting
Professional
Modifier
Global
Typical Low
$512,861.38
Median
$512,861.38
Typical High
$1,000,000.00
Cigna
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$588,843.66
Fallon Health
Setting
Facility
Modifier
Global
Typical Low
$3,630.78
Median
$588,843.66
Typical High
$758,577.58
Harvard Pilgrim
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$489,778.82
Mass General Brigham
Setting
Facility
Modifier
Global
Typical Low
$426,579.52
Median
$977,237.22
Typical High
$1,659,586.91
Mass General Brigham
Setting
Professional
Modifier
Global
Typical Low
$512,861.38
Median
$512,861.38
Typical High
$1,000,000.00
United
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$1,047,128.55
United
Setting
Professional
Modifier
Global
Typical Low
$89,125.09
Median
$89,125.09
Typical High
$660,693.45